P4.11D.04 A Phase 1/2 Study of REGN7075 (EGFRÃ-CD28) Combined with Cemiplimab (anti-PD-1) In NSCLC: Trial in Progress UpdateM.L. Johnson, Neil H. Segal, Davendra Sohal et al.|Journal of Thoracic Oncology|2024Cited by 0